Funny they left out RAD $1.58
I have liked select health-care stocks for awhile on the theme that certain companies would benefit from Obamacare. Drug stores were consistent with that theme since with 30 million more people becoming insured, foot traffic would increase not just for prescriptions, but ancillary items as well. At the time our fundamental analyst’s (John Ransom) favorite name was CVS (NYSE:CVS). Now he favors 2.8%-yielding Walgreen (NYSE:WAG $ 40.00) as he writes:
Will the January Barometer Deliver This Year?
By Jeff Saut Feb 04, 2013 9:45 am
I'm looking for a sustainable trend
RAD $ 1.58 is the way. Just off multi yr. loses and lows in stock price then beating the street and raising guidance. The flu shots are being sold out and this trend has just started and other support products are having the same demands. RAD is a gold mind and is working on refinancing a private equity group or insurance group or hospital group would do well to get RAD RAD is a great way to play on the new insurance rules. Rad valuations are just to compelling and a very big part to health care in the future front line demand. RAD is price at 1/10 it's peers WAG CVS they won't double in stock price but RAD will.